ABSTRACT
Among women worldwide, breast cancer is the most frequently diagnosed malignancy and the leading cause of death from cancer. Mammography has been the mainstay of breast cancer screening. There has been increasing interest in other modalities besides mammography for early breast cancer detection and screening, particularly for younger women at potentially high risk. Magnetic resonance imaging is gaining acceptance for screening women at increased risk for breast cancer. A missed cancer, albeit relatively less likely with Magnetic Resonance Imaging than mammography, can adversely affect prognosis. As opposed to in vivo Magnetic Resonance Spectroscopy (MRS) breast examinations based mainly upon one composite spectral entity, the high resolution of in vitro MRS applied to extracted specimens provides a much greater insight into the metabolic activity of malignant breast tissue. The chapter shows that the demonstrated advantages of the fast Pade transform could definitely be of benefit for breast cancer diagnostics via MRS.
